skip to navigation skip to content

drug development

Funding for rare diseases startup

Healx, a company that seeks breakthroughs for rare diseases through artificial intelligence, said it had secured $56 million in Series B financing, led by venture capital firm Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous investors…

Read more

Funding for rare diseases startup

Pharma journey

From Greece to Scotland Yard to providing drugs for clinical trials: Cambridge MBA alumna Vanessa Dekou (MBA 2002) built a global pharma business from scratch. Vanessa Dekou Cambridge MBA alumnus Vanessa Dekou re-mortgaged her London house to set up her…

Read more

Pile of blue, green and white pills.

Healthcare policy & drug development (The Cambridge Judge Business Debate podcast series)

How ageing societies can afford healthcare for all and reform an organisational system that has not kept pace with technology. L-R: Paul Tracey, Michael Kitson, Kamal Munir, Stefan Scholtes, Nektarios Oraiopoulos In this episode, joining podcast host Michael Kitson, University…

Read more

Healthcare Medical examination business graph marketing analysis report health

Manufacturing Chemist: Limits of drug repurposing

New research co-authored at Cambridge Judge Business School looks at drug repurposing and found that it’s not easy to find entirely new uses for existing molecules. The study is based on US Food and Drug Administration approvals and the full…

Read more

Limits of drug repurposing

Drug 'repurposing' has some high-profile wins, but a new study at Cambridge Judge Business School shows how hard it is to find entirely new uses for existing molecules. The "repurposing" of existing drugs can be valuable, but a new study…

Read more

Colorful of tablets and capsules pill in blister packaging arranged with beautiful pattern with flare light. Pharmaceutical industry concept. Pharmacy drugstore. Antibiotic drug resistance.

New funding for Healx

Healx, a rare-disease company supported by the Entrepreneurship Centre at Cambridge Judge Business School, announces a $10 million Series A funding round led by Balderton Capital. Healx, a Cambridge-based company that seeks breakthroughs for rare diseases through artificial intelligence, announced…

Read more

New funding for Healx

Forbes: Healx raises $10m in funding to find medicines for rare diseases

Healx, a Cambridge-based company that seeks breakthroughs for rare diseases through artificial intelligence, announced a $10 million Series A funding round. Healx is supported by the Accelerate Cambridge programme at the Entrepreneurship Centre of Cambridge Judge Business School. The funding…

Read more

A framework for drug development

'Science is not enough' for ensuring commercial success of new drugs, so a new journal article co-authored by Dr Nektarios (Aris) Oraiopoulos of Cambridge Judge outlines a framework to help pharma companies align better with end-customer priorities. In most industries,…

Read more

Full frame shot of pills

Archives